Genetic Analysis of a Novel Antioxidant Multi-Target Iron Chelator, M30, Protecting Against Chemotherapy-Induced Alopecia in Mice

    February 2019 in “ BMC cancer ”
    Young-Cheol Lim, Il Tae Kim, Sang Moo Lim, Jin Su Kim
    Image of study
    TLDR M30 is a promising treatment for preventing hair loss during chemotherapy.
    The study from 2019 investigated the effectiveness of a novel antioxidant multi-target iron chelator, M30, in preventing chemotherapy-induced alopecia in mice. The research involved C57BL/6 mice treated with cyclophosphamide to induce hair loss, which were then administered M30. Results showed that M30 enhanced hair growth and prevented the abnormal hair changes typically caused by cyclophosphamide. Gene expression profiles from skin biopsies identified five key genes (Tnfrsf19, Ercc2, Lama5, Ctsl, and Per1) associated with various aspects of hair growth and follicle development that were affected by the treatment. The study concluded that M30 is a promising therapy for preventing hair loss caused by chemotherapy and highlighted the potential role of the identified genes in hair cycle regulation and follicle maturation.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 143 results
      M30. thoughts onswitching from oral to topical

      community M30. thoughts onswitching from oral to topical

      in General  67 upvotes 5 days ago
      A user is considering switching from oral to topical treatments for hair loss due to side effects like watery semen and erectile dysfunction. They are currently using oral finasteride and minoxidil and are concerned about potential sexual side effects with topical use.

      community M30, 6 months of oral dut and toplical min

      in Progress Pictures  95 upvotes 1 month ago
      A user shared their 6-month progress using oral dutasteride (0.5mg daily), topical minoxidil (5% once daily), and ketoconazole shampoo (2% weekly) for hair loss, reporting increased libido and no side effects. They chose dutasteride over finasteride due to availability and convenience.

      community M30, month 5 of dutasteride and minoxidil

      in Progress Pictures  251 upvotes 2 months ago
      A 30-year-old male experienced significant hair regrowth after five months of using topical minoxidil (5% foam) and oral dutasteride (0.5 mg daily). The user reported no side effects and was grateful for the progress, despite the rapid gains slowing down.

      community M30, month 4 of dutasteride and minoxidil

      in Progress Pictures  126 upvotes 3 months ago
      A 30-year-old male is using dutasteride, minoxidil, ketoconazole shampoo, and various supplements for hair loss, reporting no sexual side effects but experiencing tinnitus. He stopped microneedling and tretinoin cream, saw quick results, and experiences low-intensity shedding.

      community M30, month 3 of dutasteride and minoxidil

      in Progress Pictures  310 upvotes 4 months ago
      A 30-year-old man shared his 3-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects. He also takes supplements like Vitamin D3, Calcium, Magnesium, and Zinc, and plans to add Biotin.

    Related Research

    6 / 6 results